Tag: Board Member

Ask the Expert with Dr. Terry Day: June 2 – 4

HNCA Chairman of the board, Terry Day, M.D, will be available from June 2 through June 4 to answer questions about COVID-19: How Head and Neck Cancer Patients and Survivors Navigate the re-opening of Communities. If you would like to ask him a question, we invite you to do so by joining the HNCA online.


Mental Health Issues in Head and Neck Cancer Patients Caused by the COVID – 19 Pandemic

By: Itzhak Brook, M.D. MSc., HNCA Board Member, HNCA Ambassador, Throat Cancer Survivor and Laryngectomee The current COVID-19 outbreak is spurring depression, fear, anxiety, and stress on a societal level. On an individual level, it may exacerbate anxiety and psychosis-like symptoms as well as lead to non-specific mental issues (e.g., mood problems, sleep issues, phobia-like.


Cancer Treatment Education Workshop with Dr. Terry Day

HNCA Chairman of the Board, Dr. Terry Day, will be part of a free CancerCare Connect® Education Workshop/Teleconference on the topic of what’s new in the treatment of oral, head and neck cancer. The workshop is scheduled for Wednesday, April 15, 2020, from 1:30 PM to 2:30 PM EST. Pre-registration is required. Register Today


Respiratory Infection Prevention for Laryngectomees

By: Itzhak Brook, M.D. MSc., HNCA Board Member, HNCA Ambassador, Throat Cancer Survivor and Laryngectomee Laryngectomees are more susceptible to respiratory infection because the air they inhale is not filtered by passing through the nose. Consequently, they are at increased risk of inhaling respiratory pathogens (viruses, bacteria, and fungi) directly into their lungs. Therefore, laryngectomees.


IA Immunization Summit featuring Dr. Moore and Jason Mendelsohn

HNCA president and executive board member, Dr. Michael Moore and Jason Mendelsohn were featured in today’s Immunization Summit as part of the two-day conference held in Altoona, Iowa and sponsored by the Iowa Department of Public Health, Immunization Program. Speakers talked about a variety of topics in relation to immunization such as the link between.


Immunotherapy Symposium in Chicago, IL

In collaboration with PeerView, HNCA will have one of our board members, Dr. Ezra Cohen, feature as the chair and presenter of the live dinner symposium. The expert panelist will be discussing the mapping progress of immune checkpoint inhibitors in head and neck cancer. The symposium will be held in Chicago, IL on May 31,.


Indiana University Health — Free Screening — Indianapolis, IN

This will be a screening and awareness event meant to educate participants in the sign, symptoms and risk factors of head and neck cancer and also to provide a free history and head and neck physical exam to look for any suspicious lesions. Members of the IUH head and neck cancer team will be in.


Visiting China: A Glimpse into Life as a Chinese Laryngectomee

By: Itzhak Brook, MD, MSc Sometimes we take our own experience for granted and forget that things may not be the same in other parts of the world. I was honored to be able to visit China and get first-hand insight into the life of Chinese laryngectomees and head and neck cancer patients. On October.


Genomics Education Workshop with Dr. Terry Day

HNCA Chairman of the Board, Dr. Terry Day, will be part of a free CancerCare Connect® Education Workshop/Teleconference for people living with oral and head and neck cancers, their families, partners, caregivers, friends and healthcare professionals. The teleconference will cover topics including an overview of the treatment of oral and head and neck cancers and.


HNCA Board Members Advocate for TEP Patients and Providers

Meryl Kaufman, MED, CCC-SLP, BCS-S, and Cherie-Ann Nathan, MD, FACS, have been conducting intensive advocacy work on behalf of laryngectomees who use TEP (tracheoesophageal voice prosthesis) in regard to issues with Medicare coverage. Click here to learn more about this issue. They recently met with the Center for Medicare and Medicaid Services (CMS), along with.


1-866-792-HNCA (4622)




I had no idea that HPV could cause head and neck cancer. I am an advocate for everyone I know. I don’t want them to experience what I and my family experienced because we did not know about this sexually transmitted virus.Tina O’Dell
Survivor of HPV-Attributed Stage III Squamous Cell


Thank You to Our Corporate and Community Partners